Buprenorphine MarketChallenges and Opportunities

Buprenorphine Market, By Application (Analgesic, Opioid Antagonist), By Route of Administration (Injectables, Sublingual, Transdermal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023

Code : CMI4237

Pages :180

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

Global Buprenorphine Market – Restraints

Adverse Side Effects Buprenorphine: The global buprenorphine market can be hindered by the increasing side effects of buprenorphine over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, buprenorphine exerts some anticholinergic-like effects and may cause central nervous system depression, hypotension, QT prolongation, and a lower seizure threshold...

Global Buprenorphine Market – Driver

Approval of Buprenorphine Treatment for Opioid Use Disorder, by Regulatory Authorities

Increasing approval of buprenorphine treatment for opioid use disorder by regulatory authorities is expected to drive the growth of the global buprenorphine market over the forecast period. For instance, on May 23, 2023, the U.S. Food and Drug Administration approved Brixadi (buprenorphine)...

Challenges and Opportunities

Increasing prevalence of cancer around the world...